A cosmetic wrinkle shot sparked one of the strangest and most useful accidents in modern medicine: people walked into a dermatologist’s office hoping to smooth their forehead and walked out with their chronic migraines quieted. We trace how that observation turned into Botox for chronic migraine, what the PREEMPT trials actually proved, and why “chronic” has a strict definition that matters if you’re trying to get the right care.

We also get honest about what the treatment really looks like: 155 units across 31 fixed injection sites, sometimes up to 40 total shots across the head, neck, and shoulders. That sounds extreme until you understand the anatomy. We break down the competing explanations for why it helps, from dampening neuropeptides like CGRP and substance P in trigeminal pathways to the more mechanical “chemical decompression” idea, where tense muscles and tight fascia physically squeeze peripheral nerves like a stone on a garden hose.

Then we hit the limits patients feel in real life: a powerful placebo effect in pain trials, a response rate that isn’t universal, the long wait across multiple 12-week cycles, and the burdens of side effects and repeat treatments. The turning point is using temporary relief as a diagnostic signal. If relaxing or numbing a specific nerve pathway shuts off the pain, that can guide targeted mapping and, for appropriately selected patients who have failed Botox, triptans, and CGRP inhibitors, peripheral nerve decompression surgery with reported high success rates. If this reframes how you think about migraines, subscribe, share this with someone who needs options, leave a review, and tell us: have you ever tried nerve blocks or trigger point mapping?

If you have questions about Botox and indications for headache surgery, find out more at headachesurgery.com or call 805-969-9004.